Firuglipel (INN; developmental code name DS-8500 or DS-8500a) is a GPR119 agonist with antihyperglycemic actions which was under development for the treatment of type 2 diabetes but was never marketed.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.